Insights

Molecular clarity Leverage QuantumCyte’s focus on image-based annotation that translates into molecular clarity to position offerings that shorten time-to-decision for researchers and diagnostics teams, highlighting value in faster, more confident test results.

Integrated platforms Target customers seeking seamless digital pathology and spatial biology workflows by aligning sales pitches around QCPRECISE as a connective tissue between imaging, molecular testing, and downstream analytics.

Growth-ready team With a lean team and a broad skill set in genomics, software, and product development, present scalable collaboration and rapid integration capabilities to mid-market labs and early-stage biotech startups needing agile partnerships.

Funding and scale Even with modest current funding and revenue, emphasize potential for expansion through strategic customers and co-development opportunities with larger players in sequencing, diagnostics, and therapeutic development.

Tech-forward appeal Highlight the cloud and web-based tech stack (AWS, Webflow, WordPress, modern web tech) as a selling point for cost-effective deployment, secure data handling, and easy customization for lab environments.

Similar companies to QuantumCyte, Inc.

QuantumCyte, Inc. Tech Stack

QuantumCyte, Inc. uses 8 technology products and services including Amazon Web Services, WordPress, Microsoft 365, and more. Explore QuantumCyte, Inc.'s tech stack below.

QuantumCyte, Inc.'s Email Address Formats

QuantumCyte, Inc. uses at least 1 email format:
QuantumCyte, Inc. Email FormatsExamplePercentage
FLast@quantumcyte.comJDoe@quantumcyte.com
100%

Frequently Asked Questions

What is QuantumCyte, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
QuantumCyte, Inc.'s official website is quantumcyte.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does QuantumCyte, Inc. generate?

Minus sign iconPlus sign icon
As of August 2026, QuantumCyte, Inc.'s annual revenue is estimated to be $1M - $10M.

What is QuantumCyte, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
QuantumCyte, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does QuantumCyte, Inc. have currently?

Minus sign iconPlus sign icon
As of August 2026, QuantumCyte, Inc. has approximately 15 employees across 2 continents, including North America and Asia. Key team members include Chief Product Officer: S. K. Explore QuantumCyte, Inc.'s employee directory with LeadIQ.

What industry does QuantumCyte, Inc. belong to?

Minus sign iconPlus sign icon
QuantumCyte, Inc. operates in the Biotechnology Research industry.

What technology does QuantumCyte, Inc. use?

Minus sign iconPlus sign icon
QuantumCyte, Inc.'s tech stack includes Amazon Web Services, WordPress, Microsoft 365, jQuery Migrate, Webflow, Bootstrap, Apache and OpenResty.

What is QuantumCyte, Inc.'s email format?

Minus sign iconPlus sign icon
QuantumCyte, Inc.'s email format typically follows the pattern of FLast@quantumcyte.com. Find more QuantumCyte, Inc. email formats with LeadIQ.

How much funding has QuantumCyte, Inc. raised to date?

Minus sign iconPlus sign icon
As of August 2026, QuantumCyte, Inc. has raised $1.1M in funding. The last funding round occurred on Aug 15, 2023 for $1.1M.

When was QuantumCyte, Inc. founded?

Minus sign iconPlus sign icon
QuantumCyte, Inc. was founded in 2013.
QuantumCyte, Inc. logo

QuantumCyte, Inc.

Biotechnology ResearchCalifornia, United States11-50 Employees

QuantumCyte, Inc. operates in the biotechnology research sector with a focus on integrating digital pathology, spatial biology, and molecular testing. Its platform, QCPRECISE, translates image-based annotations into molecular insights, aiming to reduce ambiguity in biopsies and enable faster, more confident decision-making across research, diagnostics, and therapeutic development. The company positions itself as connecting imaging data with molecular clarity to support clinicians, researchers, and patients through clearer test results.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
11-50

Section iconFunding & Financials

  • $1.1M

    QuantumCyte, Inc. has raised a total of $1.1M of funding over 6 rounds. Their latest funding round was raised on Aug 15, 2023 in the amount of $1.1M as a Series A.

  • $1M - $10M

    QuantumCyte, Inc.'s revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.